Ranbaxy Laboratories Ltd.
 
Bse Code: 500359 | NSE CODE: RANBAXY | Sector: Pharmaceuticals & Drugs
Prev Close
Open
MarketCap(` in Cr.)
Volume (No. of shares)
52 W LOW
52 W HIGH
LOW
HIGH

price chart

News

Experts suggest buying pharma stocks like DRL, Ranbaxy and Sun Pharma.
Ranbaxy Laboratories has opened a new production facility in Morocco, a move which would help the drug maker access the Afri...

financial summary

` in Cr.DEC 2011DEC 2010yoy(%)
Net Sales7,685.335,669.5435.55
Total Expenditure6,437.014,439.7244.99
Operating Profit1,601.261,593.210.51
Interest603.5654.191,013.70
PBDT997.701,539.01-35.17
Depreciation274.08228.3520.03
PAT-3,052.051,148.73-365.69

Research

Ratios

Earnings Per Share (Rs)-72.32
Book NAV by Share(Rs)45.32
EBIT Margin(%)-31.72
PAT Margin (%)-39.59
ROCE(%)-31.24
Price by Book(x)8.94
Yield(%)0.00
PAT Growth(%)-365.69
Total Debt by Equity(x)2.27

More About this company on NDTV Profit

No Interviews/Opinions found.

announcement / Events


Dateannouncement / events
Apr 25, 2012
03:51 PM
Ranbaxy Launches Synriam - India`s First New Drug
May 08, 2012
12:15 PM
Outcome of AGM
May 09, 2012
01:38 PM
Announces Q1 results & Limited Review Report for the period March 31, 2012
May 09, 2012
01:47 PM
Outcome of Board Meeting

shareholding pattern

DescriptionPercent of Share(%)
Total Promoter63.67
GovtN.A
FII9.56
Institutions20.47

Corporate Information

Sunil Godhwani
Director
Malvinder Mohan Singh
Managing Director
Atul Sobti
Chief Operating Officer & Whole-time Director
 
Registered Office:
A-41, Industrial Area Phase V I I I - A
Sahibzada Ajit Singh Nagar,
Mohali,Punjab.
Tel : 91-172 6678666
 
Registrars Details:
Alankit Assignments Ltd
Alankit House , 2 E/21,
Jhandewala Extension,
New Delhi

peer companies

MARKETS

TOP VIDEO

46:26